Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$20.4 - $24.73 $20,175 - $24,457
-989 Reduced 31.14%
2,187 $49,000
Q3 2022

Nov 09, 2022

BUY
$22.29 - $35.04 $22,044 - $34,654
989 Added 45.22%
3,176 $84,000
Q2 2022

Aug 11, 2022

BUY
$19.35 - $35.04 $42,318 - $76,632
2,187 New
2,187 $54,000
Q4 2021

Feb 11, 2022

SELL
$30.19 - $40.28 $30,280 - $40,400
-1,003 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$29.09 - $45.68 $7,941 - $12,470
273 Added 37.4%
1,003 $42,000
Q2 2021

Aug 10, 2021

SELL
$32.46 - $40.48 $102,898 - $128,321
-3,170 Reduced 81.28%
730 $28,000
Q1 2021

May 12, 2021

SELL
$33.61 - $49.95 $220,985 - $328,421
-6,575 Reduced 62.77%
3,900 $133,000
Q4 2020

Feb 10, 2021

BUY
$26.52 - $49.35 $277,797 - $516,941
10,475 New
10,475 $475,000
Q3 2020

Nov 12, 2020

SELL
$27.01 - $40.26 $15,746 - $23,471
-583 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$27.75 - $43.44 $386,529 - $605,075
-13,929 Reduced 95.98%
583 $21,000
Q1 2020

May 13, 2020

SELL
$21.5 - $54.2 $118,680 - $299,184
-5,520 Reduced 27.56%
14,512 $470,000
Q4 2019

Feb 10, 2020

BUY
$34.54 - $44.87 $689,625 - $895,874
19,966 Added 30251.52%
20,032 $821,000
Q3 2019

Nov 12, 2019

SELL
$31.84 - $50.88 $1.27 Million - $2.03 Million
-39,964 Reduced 99.84%
66 $2,000
Q2 2019

Aug 09, 2019

BUY
$42.0 - $59.29 $447,888 - $632,268
10,664 Added 36.31%
40,030 $2.06 Million
Q1 2019

May 13, 2019

SELL
$40.82 - $62.45 $702,716 - $1.08 Million
-17,215 Reduced 36.96%
29,366 $1.68 Million
Q4 2018

Feb 06, 2019

BUY
$39.11 - $75.15 $1.72 Million - $3.31 Million
44,002 Added 1706.17%
46,581 $1.95 Million
Q3 2018

Nov 08, 2018

BUY
$65.0 - $82.15 $27,625 - $34,913
425 Added 19.73%
2,579 $195,000
Q2 2018

Aug 14, 2018

BUY
$27.2 - $74.35 $12,947 - $35,390
476 Added 28.37%
2,154 $155,000
Q1 2018

May 11, 2018

BUY
$24.05 - $37.5 $33,766 - $52,650
1,404 Added 512.41%
1,678 $50,000
Q4 2017

Feb 09, 2018

BUY
$26.0 - $34.6 $7,124 - $9,480
274
274 $9,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $420M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.